Teva Pharmaceutical Industries (TEVA) Exchange Rate Effect (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Exchange Rate Effect came in at -$5.0 million in Q2 2026, little changed YoY from -$5.0 million in Q2 2025, and up 70.59% on a QoQ basis from -$17.0 million in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Exchange Rate Effect data on file, last reported at -$5.0 million in Q2 2026.
- Quarterly Exchange Rate Effect changed 0.0% year-over-year to -$5.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$41.0 million (down 315.79% YoY) and the FY2025 annual result came in at $21.0 million, up 112.07% from the prior year.
- Exchange Rate Effect improved to -$5.0 million in Q2 2026, from -$17.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $146.0 million in Q4 2022 to a low of -$123.0 million in Q2 2022.
- A 5-year average of -$18.2 million and a median of -$13.5 million in 2025 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 404.17% in 2022, down 2360.0% in 2022.
- Tracing TEVA's Exchange Rate Effect over 5 years: stood at $146.0 million in 2022, then tumbled by 53.42% to $68.0 million in 2023, then slumped by 277.94% to -$121.0 million in 2024, then surged by 91.74% to -$10.0 million in 2025, then jumped by 50.0% to -$5.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$5.0 million (Q2 2026), -$17.0 million (Q1 2026), and -$10.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.00 Mn |
| Jun 30, 2026 | -5.00 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Sep 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Mar 31, 2025 | 45.00 Mn |
| Mar 31, 2025 | 45.00 Mn |
| Dec 31, 2024 | -121.00 Mn |
| Dec 31, 2024 | -121.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | -49.00 Mn |
| Jun 30, 2024 | -49.00 Mn |
| Mar 31, 2024 | -104.00 Mn |
| Mar 31, 2024 | -104.00 Mn |